ADDENDUM: Section E9 of the American College of Medical Genetics Technical Standards and Guidelines: Fluorescence in situ hybridization.

Autor: Mascarello JT; Genzyme Genetics, Santa Fe, NM, USA., Hirsch B; University of Minnesota Medical School, Minneapolis, MN, USA., Kearney HM; Fullerton Genetics Center, Asheville, NC, USA., Ketterling RP; Mayo Clinic College of Medicine, Rochester, MN, USA., Olson SB; Oregon Health and Science University, Portland, OR, USA., Quigley DI; Kaiser Permanente, NW, Portland, OR, USA., Rao KW; University of North Carolina, Chapel Hill, NC, USA., Tepperberg JH; Laboratory Corp America, Research Triangle Park, NC, USA., Tsuchiya KD; Seattle Children's Hospital and University of Washington Medical Center, Seattle, WA, USA., Wiktor AE; Mayo Clinic College of Medicine, Rochester, MN, USA.

Publikováno v: Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2019 Oct; Vol. 21 (10), pp. 2405.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in situ hybridization.

Autor: Diks J; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tang Z; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Altan M; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Anderson S; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chen H; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rashid A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yang RK; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Routbort MJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Toruner GA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tang G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Luthra R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Roy-Chowdhuri S; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publikováno v: Cancer cytopathology [Cancer Cytopathol] 2024 Jan; Vol. 132 (1), pp. 41-49. Date of Electronic Publication: 2023 Sep 25.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.